# When the Insurer Walked Away, the Government Stepped In - Date: 2026-04-22 - Category: Biotech & Life Sciences Private insurers refused to cover GLP-1 obesity drugs for Medicare patients. The Trump administration built a parallel financing system outside the insurance market, taxpayer-funded, running through 2027. Amazon announced its own GLP-1 program the same week. ---